Diagnostic value of interleukin 22 and carcinoembryonic antigen in tuberculous and malignant pleural effusions

Experimental and Therapeutic Medicine

Volumn 2, Issue 6, 2011, Pages 1205-1209

  Jin, Di ^a,b   Chen, Ying ^a   Wang, Zhengyun ^a   Wang, Siwei ^a   Bunjhoo, Hansvin ^a   Zhu, Jing ^a   Cao, Yong ^a   Xiong, Weining ^a   Xiong, Shengdao ^a   Xu, Yongjian ^a   Fang, Huijuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Hubei College of Chinese Medicine   (China)

Author keywords

Carcinoembryonic antigen; Differential diagnosis; Interleukin 22; Pleural effusion

Indexed keywords

ADENOSINE DEHYDROGENASE; CARCINOEMBRYONIC ANTIGEN; INTERLEUKIN 22; LACTATE DEHYDROGENASE; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PLEURA EFFUSION; SENSITIVITY AND SPECIFICITY; TUBERCULOUS PLEURISY;

EID: 80052723518     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.344     Document Type: Article

References (29)

1. Doelken P: Clinical implications of unexplainable lung due to pleural disease. Am J Med Sci 335: 21-25, 2008.
2. Khaleeq G and Musani AI: Emerging paradigms in the management of malignant pleural effusions. Respir Med 102: 939-948, 2008.
3. Musani AI: Treatment options for malignant pleural effusion. Curr Opin Pulm Med 15: 380-387, 2009.
4. Spector M and Pollak JS: Management of malignant pleural effusions. Semin Respir Crit Care Med 29: 405-413, 2008.
5. Heffner JE: Diagnosis and management of malignant pleural effusions. Respirology 13: 5-20, 2008.
6. Yang HB and Shi HZ: T lymphocytes in pleural effusion. Chin Med J (Engl) 121: 579-580, 2008.
7. + regulatory T lymphocytes in tuberculous pleural effusion. Chin Med J (Engl) 121: 581-586, 2008.
8. Infante-Duarte C, Horton HF, Byrne MC and Kamradt T: Microbial lipopeptides induce the production of IL17 in Th cells. J Immunol 165: 6107-6115, 2000.
9. + T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141, 2005.
10. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1133, 2005.
11. Harrington LE, Mangan PR and Weaver CT: Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 18: 349-356, 2006.
12. Weaver CT, Harrington LE, Mangan PR, Gavrieli M and Murphy KM: Th 17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688, 2006.
13. Wang T, Lv M, Qian Q, Nie Y, Yu L and Hou Y: Increased frequencies of T helper type 17 cells in tuberculous pleural effusion. Tuberculosis 91: 231-237, 2011.
14. Wolk K, Witte E, Witte K, Warszawska K and Sabat R: Biology of interleukin-22. Semin Immunopathol 32: 17-31, 2010.
15. Dumoutier L, Lejeune D, Colau D and Renauld JC: Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. JImmunol 166: 7090-7095, 2001.
16. Wolk K and Sabat R: Interleukin-22: a novel T and NK cell-derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17: 367-380, 2006.
17. Aggarwal S, Xie MH, Maruoka M, Foster J and Gurney AL: Acinar cells of the pancreas are a target of interleukin-22. J Interferon Cytokine Res 21: 1047-1053, 2001.
18. Wolk K, Witte E, Wallace E, Döcke WD, Kunz S, Asadullah K, Volk HD, Sterry W and Sabat R: IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 36: 1309-1323, 2006.
19. Schmechel S, Konrad A, Diegelmann J, Glas J, Wetzke M, Paschos E, Lohse P, Göke B and Brand S: Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status. Inflamm Bowel Dis 14: 204-212, 2008.
20. Schnyder B, Lima C and Schnyder-Candrian S: Interleukin-22 is a negative regulator of the allergic response. Cytokine 50: 220-227, 2010.
21. Qiao D, Yang BY, Li L, Ma JJ, Zhang XL, Lao SH and Wu CY: ESAT-6-and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection. Scand J Immunol 73: 330-337, 2011.
22. Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J and Tian Z: Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin Cancer Res 14: 6432-6439, 2008.
23. Dumoutier L, Lejeune D, Colau D and Renauld JC: Cloning and characterization of IL-10 related T cell derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 164: 1814-1819, 2000.
24. Aujla SJ and Kolls JK: IL-22: a critical mediator in mucosal host defense. J Mol Med1 87: 451-454, 2009.
25. Dumoutier L, van Roost E, Colau D and Renauld JC: Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as a hepatocyte-stimulating factor. Proc Natl Acad Sci USA 97: 10144-10149, 2000.
26. Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP and Pestka S: Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 276: 2725-2732, 2001.
27. Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, Ueki K and Nojima Y: Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 52: 1037-1046, 2005.
28. Boucher D, Cournoyer D, Stanners CP and Fuks A: Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. Cancer Res 49: 847-852, 1989.
29. Shi HZ, Liang QL, Jiang J, Qin XJ and Yang HB: Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis. Respirology 13: 518-527, 2008.